GlobeNewswire by notified

Sampo completes its share buyback programme

Share

SAMPO PLC                        STOCK EXCHANGE RELEASE                  18 May 2022 at 9:15 am


Sampo completes its share buyback programme

Sampo plc has now completed its share buyback programme. The repurchases of shares began on 31 March 2022 and ended on 17 May 2022. During that period, Sampo repurchased 4,961,994 of its own shares at an average price per share of EUR 45.85. The amount corresponds to 0.9 per cent of all Sampo plc’s shares. The repurchase of own shares has reduced the company's unrestricted equity by approximately EUR 228 million.

The purpose of the buyback programme was to return excess capital to shareholders by reducing Sampo plc’s capital, as the repurchased shares will be cancelled.

Management intends to propose to the Board that a new share buyback programme is launched after the Annual General Meeting on 18 May 2022, subject to the AGM renewing the Board authorisation on share repurchases. The Board will make a decision on the proposal at the next regular meeting, which takes place on 9 June 2022.


SAMPO PLC
Investor Relations and Group Communications

For further information, please contact:

Sami Taipalus
Head of Investor Relations
tel. +358 10 516 0030

Maria Silander
Communications Manager, Media Relations
tel. +358 10 516 0031

Distribution:
Nasdaq Helsinki
London Stock Exchange
The principal media
Financial Supervisory Authority
www.sampo.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Forløb af ordinær generalforsamling i Investeringsforeningen Stonehenge den 24. april 202424.4.2024 10:30:00 CEST | pressemeddelelse

Bestyrelsens beretning Bestyrelsens beretning blev taget til efterretning af generalforsamlingen. Årsrapport,udbytte og bestyrelsesmedlemmernes honorar Årsrapporten for 2023 blev enstemmigt godkendt, herunder bestyrelsens honorar samt forslag om udbetaling af udbytte på 6,90 kr. pr. bevis for Globale Valueaktier KL og 3,80 kr. pr. bevis for Globale Valueaktier PM KL. Udbyttebetalingen til investorerne er foretaget aconto den 8. februar 2024. Valg til bestyrelsen Bestyrelsen havde indstillet til genvalg af Henrik Bærtelsen. Henrik Bærtelsen blev enstemmigt valgt som medlem af bestyrelsen. Valg af revisor EY Godkendt Revisionspartnerselskab blev genvalgt som revisor for foreningen. Bestyrelsen for Investeringsforeningen Stonehenge c/o BI Management A/S Bredgade 40 1260 København K

Prosafe SE: Q1 2024 results and webcast on May 8, 202424.4.2024 10:16:48 CEST | Press release

Prosafe SE will release its first quarter 2024 results on May 8, 2024, at approximately 07:00 a.m. CET. The Q1 2024 presentation will be published on www.newsweb.no and on Prosafe’s website www.prosafe.com. Terje Askvig, CEO, and Reese McNeel, CFO, will, on the same day at 10:00 a.m. CET, present the results at Pareto Securities, Dronning Mauds gate 3, 0115 Oslo. The presentation is open to the public and can also be followed live via web streaming at www.prosafe.com. It will be possible to ask questions during the presentation by using the Q&A tool embedded in the webcast. These questions will be answered after the presentation. A replay of the audiocast will be made available on Prosafe’s website shortly after. Prosafe is a leading owner and operator of semi-submersible accommodation vessels. The company is listed on the Oslo Stock Exchange with ticker code PRS. For more information, please refer to www.prosafe.com. Stavanger, 24 April 2024 Prosafe SE For further information, please

Debitormassens sammensætning, Realkredit Danmark A/S24.4.2024 10:12:43 CEST | pressemeddelelse

Til Nasdaq Copenhagen A/S Direktionen Bernstorffsgade 40 1577 København V www.rd.dk Telefon 7012 5300 24. april 2024 Selskabsmeddelelse nummer 31/2024 Debitormassens sammensætning for konverterbare obligationsserier, Realkredit Danmark A/S I medfør af lov om kapitalmarkeder §24 oplyses hermed om debitormassens sammensætning vedrørende Realkredit Danmark A/S pr. fredag den 19. april 2024. Oplysningerne fremgår af vedhæftede datafil. Oplysningerne vil desuden kunne ses på Realkredit Danmarks hjemmeside på www.rd.dk. For yderligere oplysninger om dataformat og -indhold henvises til Nasdaq Copenhagen A/S’s hjemmeside. Med venlig hilsen Direktionen Eventuel henvendelse kan rettes til chefanalytiker Hella Gebhardt Rønnebæk, 45 13 20 68. Vedhæftede filer Nr. 31_Debitormassens sammensaetning_DKBilag til selskabsmeddelelse nr. 31-2024

Breakdown of debtors, Realkredit Danmark A/S24.4.2024 10:12:43 CEST | Press release

To Nasdaq Copenhagen A/S Executive Management Bernstorffsgade 40 DK-1577 København V www.rd.dk Telephone +45 7012 5300 24 April 2024 Company Announcement No 31/2024 Breakdown of debtors, Realkredit Danmark A/S Pursuant to §24 of the Capital Markets Act, Realkredit Danmark A/S hereby publishes breakdown of debtors as of Friday 19 April 2024. Please find the data in the attached file. The information will also be available on www.rd.dk. Yours sincerely The Executive Management Any additional questions should be addressed to Hella Gebhardt Rønnebæk, Chief Analyst, phone +45 4513 2068. Attachments Nr. 31_Debitormassens sammensaetning_UKBilag til selskabsmeddelelse nr. 31-2024

Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)24.4.2024 10:00:00 CEST | Press release

The confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid arthritisAlvotech is the first company to publicly announce positive topline results from a patient study evaluating a biosimilar candidate to Simponi or Simponi Aria Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive topline results from a confirmatory clinical study for AVT05, Alvotech’s proposed biosimilar to Simponi® and Simponi Aria® (golimumab). Alvotech is the first company to announce positive topline results of a clinical trial using a proposed biosimilar to Simponi and Simponi Aria and is one of only two companies known to have initiated such a patient study. “We are delighted at passing yet another clinical milestone in our pipeline,” said Robert Wessman, Chairm

HiddenA line styled icon from Orion Icon Library.Eye